The Value of Biosimilar Medicines

European Parliament Hearing on the Overreliance on Imports of Active Pharmaceutical Ingredients (APIs)

Key BIOS facts and Figures – 2025

Proposals to Accelerate the EU Integration of the Ukrainian Pharmaceutical Industry

(Short version) Critical Medicines Act: delivering a secure supply of critical medicines and active pharmaceutical ingredients in Europe

Position Papers on Electronic Product Information (ePI)

Streamlining Biosimilar Development: Key Aspects

Market Access Barriers: An overview of key barriers to generic and biosimilar market entry in select EU trading partners

Position Paper on the Overreliance on imports of Active Pharmaceutical Ingredients (APIs)

European Critical Medicines Act

Open